![Suhail Ayesh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Suhail Ayesh
Corporate Officer/Principal chez The Hebrew University of Jerusalem
Profil
Suhail Ayesh is Senior Researcher of BioCancell Therapeutics, Inc. He is Professor of Molecular Biochemistry and Gene Therapy at the Hebrew University of Jerusalem.
Mr. Ayesh is a Director of the Molecular Genetics Laboratory for Makassed Hospital.
Postes actifs de Suhail Ayesh
Sociétés | Poste | Début |
---|---|---|
The Hebrew University of Jerusalem | Corporate Officer/Principal | - |
Al-Makassed Hospital | Corporate Officer/Principal | - |
Anciens postes connus de Suhail Ayesh
Sociétés | Poste | Fin |
---|---|---|
BioCancell Therapeutics, Inc.
![]() BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
BioCancell Therapeutics, Inc.
![]() BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
Al-Makassed Hospital |